Ultragenyx Pharmaceutical Inc. ( RARE) - Key Metrics
RARE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.07 | -$1.29 | ? | ? |
| 2025Q3 | $1.60 | -$1.81 | -$0.92 | -$0.93 |
| 2025Q2 | $1.69 | -$1.17 | -$1.10 | -$0.97 |
| 2025Q1 | $1.45 | -$1.57 | -$1.73 | -$1.90 |
RARE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -4.45 |
| 2025Q3 | ? | -4.16 |
| 2025Q2 | ? | -7.79 |
| 2025Q1 | ? | -5.77 |
RARE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -9.39% | ? |
| 2025Q4 | -4.39% | ? |
| 2025Q3 | -3.09% | ? |
| 2025Q2 | -2.67% | ? |
| 2025Q1 | -5.24% | ? |
RARE
Price: $25.38
52 week price:
Payout Ratio Range:
Earnings Per Share: -6.10 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 449700
Ebitda: -96.8 millionMarket Capitalization: 2.3 billion